Companies / Abbott Laboratories
Abbott Laboratories
Financials · FY2025
Ownership
1.73B shares outstanding · as of Jun 30, 2026
Ownership
| Insiders | 0.47% | 8,178,621 |
| Institutions | 83.93% | 1,452,246,673 |
| Public float | 15.60% | 269,958,002 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 18
View all →| Insider | % of shares | Shares |
|---|---|---|
Starks Daniel JDirector | 0.39% | 6,738,817 |
Ford Robert BCEOCHAIRMAN AND CEO · Director | 0.03% | 522,664 |
Salvadori Daniel Gesua SiveEVP AND GROUP PRESIDENT | <0.01% | 146,377 |
Conroy Kevin TDirector | <0.01% | 133,737 |
Moreland Mary KEXECUTIVE VICE PRESIDENT | <0.01% | 104,291 |
Earnhardt Lisa DEVP AND GROUP PRESIDENT | <0.01% | 90,407 |
Scoggins Christopher JEXECUTIVE VICE PRESIDENT | <0.01% | 77,126 |
Morrone Louis H.EXECUTIVE VICE PRESIDENT | <0.01% | 76,843 |
Boudreau Philip PEVP AND CFO | <0.01% | 71,172 |
Orville Jacob aSenior Vice President | <0.01% | 50,493 |
Institutional holders 3,280
View all →| Holder | Value | % of shares |
|---|---|---|
| $22.00B | 10.15% | |
| $13.84B | 8.82% | |
| $7.92B | 3.65% | |
| $7.34B | 4.68% | |
| $4.91B | 2.26% | |
| $4.60B | 2.12% | |
| $4.00B | 2.26% | |
| $2.94B | 1.36% | |
| $2.94B | 1.35% | |
| $2.78B | 1.28% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Norges Bank 13F manager | Exit | — | $-2.94B | -23.5M -100.00% | — | high |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | New | — | $655.94M | +6.4M | 6,388,828 0.37% of shares | high |
| Q1 2026 as of | AllianceBernstein L.P. 13F manager | Trim | — | $-583.08M | -4.7M -37.37% | 7,798,129 0.45% of shares | high |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $513.11M | +5.7M +3.85% | 152,563,476 8.82% of shares | high |
| Q2 2024 as of | Barclays PLC 13F manager | Add | — | $488.45M | +4.7M +157.70% | 7,681,463 0.44% of shares | high |
| Q2 2026 as of | Deutsche Bank AG 13F manager | Add | — | $465.25M | +5.1M +44.28% | 16,706,669 0.97% of shares | high |
| Q1 2026 as of | Polen Capital Management LLC 13F manager | Trim | — | $-405.24M | -3.9M -99.62% | 15,081 <0.01% of shares | high |
| Q1 2026 as of | D. E. Shaw & Co., Inc. 13F manager | Add | — | $403.17M | +3.9M +290.19% | 5,280,054 0.31% of shares | high |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ABT | — | 002824100 |